Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	CAP-IT Center for LNP RNA Immunoprevention	5U54CA272688-04	John Clifford, Ph.D.
Liu, Changchun	University Of Connecticut Sch Of Med/Dnt United States	Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care	3U01CA269147-04S1	Christos Patriotis, Ph.D., M.Sc.
Liu, Yang	University Of Illinois At Urbana-Champaign United States	Imaging nanoscale chromatin folding in early carcinogenesis	5R01CA254112-07	Matthew Young, Ph.D.
Livneh, Zvi	Weizmann Institute Of Science United States	Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort	5U01CA279001-03	Claire Zhu, Ph.D.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms	5R01CA247220-05	Christos Patriotis, Ph.D., M.Sc.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer	5R01CA254036-05	Matthew Young, Ph.D.
Lowry, Kathryn Paige	University Of Washington United States	Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations	5R37CA292399-02	Claire Zhu, Ph.D.
Lu, Junxuan	Pennsylvania State Univ Hershey Med Ctr United States	Early clinial trials for Angelica herbal supplements for prostate cancer interception	4R01CA260901-04	Gabriela Riscuta, M.D., CNS
Lubman, David M.	University Of Michigan At Ann Arbor United States	Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach	5R01CA160254-14	Matthew Young, Ph.D.
Lyden, David Charles	Weill Medical Coll Of Cornell Univ United States	Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection	5R01CA218513-08	Matthew Young, Ph.D.
Maclean, Paul S.	University Of Colorado Denver United States	Novel dietary interventions for reducing obesity-associated breast cancer	5R01CA258766-04	Young Kim, Ph.D.
Madeleine, Margaret M	Fred Hutchinson Cancer Center United States	Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center	3U54CA242977-07S4	Maria Silvina Frech, Ph.D., M.S.
Mahan, Kristin Eckel	University Of Texas Hlth Sci Ctr Houston United States	Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain	1R21CA292148-01	John Clifford, Ph.D.
Maitra, Anirban	New York University School Of Medicine United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	7U01CA200468-09	Matthew Young, Ph.D.
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-09	Matthew Young, Ph.D.